1 / 4

Cancer biomarkers

Cancer biomarkers offers great opportunity in improving management of cancer patients by enhancing the efficiency of detection and efficacy of the treatment. Biomarkers of cancer includes various biochemical components such as proteins, sugars, lipids, nucleic acids, small metabolites, cytogenetic and cytokinetic parameters, and whole tumor cells, which are found in body fluid. Molecular alterations used for cancer diagnosis involves application of DNA, RNA, microRNAs, and proteins.

Aarav658
Download Presentation

Cancer biomarkers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Biomarkers Market to Receive Overwhelming Hike in Revenues by 2028 Cancer biomarkers are traceable substances or molecules that indicate the existence of cancerous cells in the body.The prevention of cancer by diagnosing and analyzing various cancer biomarkers using different diagnostic techniques is a profound approach to obtain rapid results for treatment. There are various types of biomarkers such as proteins, peptides, antibodies, and nucleic acids. Presence of these biomarkersin tissues, urine, serum, blood, and other body fluids indicate an abnormal process or a disease. Various such biomarkers for cancer indications have been studied and are used as biomarkers for diagnostics, prognostics, personalized medicines, and surrogate endpoints.The identification of different types of biomarkers is an integral part of various industries such as healthcare and pharmaceuticals. Get more information on this report: Request Sample Pages Comprehensive competitive analysis and profiles of major market players such as, Abbott Laboratories, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, Exact Sciences Corporation,F.Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer, Inc., Qiagen N.V., Siemens AG, and Thermo Fisher Scientific, Inc. are provided in this report. Key Benefits For Stakeholders:  The cancer biomarkersmarket share and analysis is based on a comprehensive analysis of key developments in the cancer biomarkersindustry.  The development strategies adopted by the key cancer biomarkers market players are enlisted to understand the competitive scenario of the global market.  The study provides an in-depth analysis of the cancer biomarkersmarket trends to elucidate the imminent invest- ment pockets.  The global market trends are studied from 2019 to 2027.  Information about key drivers, restrains, and opportunities and their impact analysis on the cancer bi- omarkersmarket size is provided.  Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.  The quantitative analysis of the market from 2020 to 2027 is provided to determine the market potential.

  2. Get PDF Overlook Of Cancer Biomarkers Key Market Segments: By Profiling Technology  Omic Technologies  Imaging Technologies  Immunoassays  Cytogenetics-based Tests By Biomolecule  Genetic Biomarkers  Protein Biomarkers  Glyco-biomarkers By Cancer Type  Breast Cancer  Lung Cancer  Colorectal Cancer  Prostate Cancer  Stomach Cancer  Others By Application  Diagnostics  Drug Discovery and Development  Prognostics  Risk Assessment  Others

  3. Table of Contents: 1.Research Objectives and Assumptions oResearch Objectives oAssumptions oAbbreviations 2.Market Purview oReport Description  Market Definition and Scope oExecutive Summary  Market Snapshot, By Biomarker Type  Market Snapshot, By Cancer Type  Market Snapshot, By End User  Market Snapshot, By Region oCoherent Opportunity Map (COM) 3.Market Dynamics, Regulations, and Trends Analysis oMarket Dynamics  Drivers  Restraints  Market Opportunities oImpact Analysis oMarket Trends oRecent Developments oAcquisitions and Partnerships Scenario oTechnology Overview oRegulatory Scenario oPEST Analysis 4.Global Cancer Biomarkers Market- Impact of Coronavirus (Covid-19) Pandemic oOverall Impact oImpact on Supply and Demand oCOVID-19 Impact on the market 5.Global Cancer Biomarkers Market, By Biomarker Type, 2017 – 2030, (US$ Million) oOverview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2018 – 2030  Segment Trends oProtein Biomarkers

  4. Overview   Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) oGenetic Biomarkers  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) oOther Cancer Biomarkers Purchase This Premium Report With Flat USD 2000 OFF About US: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defence, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: sales@coherentmarketinsights.com

More Related